Fol. Biol. 2026, 72, 136-143
https://doi.org/10.14712/fb2026.0014
Research on the Diagnostic Potential of miR-383-5p in Rheumatoid Arthritis
Baohui Zhao
, Wei Liu, Yifan Wang
, Wei Liu, Yifan Wang
Comprehensive Orthopedics, Affiliated Hospital of Hebei University, 071000, Baoding City, Hebei Province, China
Received December 18, 2025
Accepted March 27, 2026
References
1. , D., Neogi, T., Silman, A. J. et al. (2010) 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 62(9), 2569-2581.
<https://doi.org/10.1002/art.27584>
2. , X., Wang, L., Li, H. et al. (2024) MiR-383-5p inhibits the proliferation and migration of lung adenocarcinoma cells by targeting SHMT2. J. Cancer 15, 2746-2758.
<https://doi.org/10.7150/jca.89733>
3. , E., Henc, I., Daca, A. et al. (2017) Autoantibodies, C-reactive protein, erythrocyte sedimentation rate and serum cytokine profiling in monitoring of early treatment. Cent. Eur. J. Immunol. 42, 259-268.
<https://doi.org/10.5114/ceji.2017.70968>
4. , A., Nahid, M. A., Satoh, M. et al. (2011) MicroRNAs in rheumatoid arthritis. FEBS Lett. 585, 3667-3674.
<https://doi.org/10.1016/j.febslet.2011.05.020>
5. , C., Xu, L., Zhang, R. et al. (2022) MicroRNA-mediated epigenetic regulation of rheumatoid arthritis susceptibility and pathogenesis. Front. Immunol. 13, 838884.
<https://doi.org/10.3389/fimmu.2022.838884>
6. , A. (2014) Epidemiology, pathophysiology, and diagnosis of rheumatoid arthritis: a synopsis. Am. J. Manag. Care 20 (7 Suppl), S128-135.
7. , F., Eurelings, L., van Laar, J. et al. (2019) Relevance of erythrocyte sedimentation rate and C-reactive protein in patients with active uveitis. Graefes Arch. Clin. Exp. Ophthalmol. 257, 175-180.
<https://doi.org/10.1007/s00417-018-4174-7>
8. , M. A., Juźwik, C. A., Morquette, B. et al. (2024) A miR-383-5p signaling hub coordinates the axon regeneration response to inflammation. J. Neurosci. 44, e1822232024.
<https://doi.org/10.1523/JNEUROSCI.1822-23.2024>
9. , W., Li, X., Huang, C. et al. (2021) LncRNAs and rheumatoid arthritis: from identifying mechanisms to clinical investigation. Front. Immunol. 12, 807738.
<https://doi.org/10.3389/fimmu.2021.807738>
10. , A. A. (2024) Anti-TNF alpha and risk of lymphoma in rheumatoid arthritis: a systematic review and meta-analysis. Medicina (Kaunas) 60, 1156.
<https://doi.org/10.3390/medicina60071156>
11. , J., Xie, C., Liu, Y. et al. (2019) Up-regulation of miR-383-5p suppresses proliferation and enhances chemosensitivity in ovarian cancer cells by targeting TRIM27. Biomed. Pharmacother. 109, 595-601.
<https://doi.org/10.1016/j.biopha.2018.10.148>
12. , L., Chen, Q., Hu, K. et al. (2024) The FTO-CMPK2 pathway in fibroblast-like synoviocytes modulates rheumatoid arthritis synovial inflammation and cartilage homeostasis via mtDNA regulation. Int. J. Biol. Sci. 20, 1617-1633.
<https://doi.org/10.7150/ijbs.90677>
13. , T., Paradowska-Gorycka, A. (2022) miRNAs as biomarkers and possible therapeutic strategies in rheumatoid arthritis. Cells 11, 452.
<https://doi.org/10.3390/cells11030452>
14. , N., Kuroda, T., Kobayashi, D. (2021) Cytokine networks in the pathogenesis of rheumatoid arthritis. Int. J. Mol. Sci. 22, 10922.
<https://doi.org/10.3390/ijms222010922>
15. , Y. J., Anzaghe, M., Schülke, S. (2020) Update on the pathomechanism, diagnosis, and treatment options for rheumatoid arthritis. Cells 9, 880.
<https://doi.org/10.3390/cells9040880>
16. , Y., Yu, H., Zeng, B. et al. (2023) miR-383-5p serves as a tumor suppressor in bladder cancer by suppressing PI3K/AKT signaling pathway. Cancer Biomark. 37, 121-131.
<https://doi.org/10.3233/CBM-220379>
17. , L., Wu, D. (2021) MicroRNA-383-5p regulates osteogenic differentiation of human periodontal ligament stem cells by targeting histone deacetylase 9. Arch. Oral Biol. 129, 105166.
<https://doi.org/10.1016/j.archoralbio.2021.105166>
18. , J., Muscoli, C., Gliozzi, M. et al. (2021) Endothelial dysfunction and extra-articular neurological manifestations in rheumatoid arthritis. Biomolecules 11, 81.
<https://doi.org/10.3390/biom11010081>
19. , A., Madej, M., Wiland, P. (2016) Immunological markers of rheumatoid arthritis. Postepy Hig. Med. Dosw. (Online), 70, 251-257. (in Polish)
<https://doi.org/10.5604/17322693.1198270>
20. , D. F., Walsh, D. A. (2017) Pain mechanisms in rheumatoid arthritis. Clin. Exp. Rheumatol. 35 (Suppl 107), 94-101.
21. , S., Lee, J., Park, M. et al. (2021) Serum biomarker panel for the diagnosis of rheumatoid arthritis. Arthritis Res. Ther. 23, 31.
<https://doi.org/10.1186/s13075-020-02405-7>
22. , G., Firestein, G. S. (2020) Restoring synovial homeostasis in rheumatoid arthritis by targeting fibroblast-like synoviocytes. Nat. Rev. Rheumatol. 16, 316-333.
<https://doi.org/10.1038/s41584-020-0413-5>
23. , H., Deng, C., Chen, S. et al. (2024) Targeting pathogenic fibroblast-like synoviocyte subsets in rheumatoid arthritis. Arthritis Res. Ther. 26, 103.
<https://doi.org/10.1186/s13075-024-03343-4>
24. , A. F., Bungau, S. G. (2021) Management of rheumatoid arthritis: an overview. Cells 10, 2857.
<https://doi.org/10.3390/cells10112857>
25. , N. R., Ashworth, J. J. (2018) Role of C-reactive protein at sites of inflammation and infection. Front. Immunol. 9, 754.
<https://doi.org/10.3389/fimmu.2018.00754>
26. , F., Abdollahi, E., Rezaei, R. et al. (2018) Altered expression of microRNAs in rheumatoid arthritis. J. Cell. Biochem. 119, 478-487.
<https://doi.org/10.1002/jcb.26205>
27. , V., Firestein, G. S. (2022) Targeting fibroblast-like synoviocytes in rheumatoid arthritis. Curr. Opin. Pharmacol. 67, 102304.
<https://doi.org/10.1016/j.coph.2022.102304>
28. , J., Chen, W., Fang, Y. et al. (2023) PU.1 promotes development of rheumatoid arthritis via repressing FLT3 in macrophages and fibroblast-like synoviocytes. Ann. Rheum. Dis. 82, 198-211.
<https://doi.org/10.1136/ard-2022-222708>
29. , V. A., Van Ancum, J. M., Reijnierse, E. M. et al. (2019) Erythrocyte sedimentation rate and albumin as markers of inflammation are associated with measures of sarcopenia: a cross-sectional study. BMC Geriatr. 19, 233.
<https://doi.org/10.1186/s12877-019-1253-5>
30. , H., Lin, S., Yang, Y. et al. (2022) Significant role of long non-coding RNA MALAT1 in deep vein thrombosis via the regulation of vascular endothelial cell physiology through the microRNA-383-5p/BCL2L11 axis. Bioengineered 13, 13728-13738.
<https://doi.org/10.1080/21655979.2022.2080412>
31. , J., Yan, S., Yang, J. et al. (2019) Non-coding RNAs in rheumatoid arthritis: from bench to bedside. Front. Immunol. 10, 3129.
<https://doi.org/10.3389/fimmu.2019.03129>
32. , J. (2012) Erythrocyte sedimentation rate as a marker for coronary heart disease. Vasc. Health Risk Manag. 8, 219-223.
<https://doi.org/10.2147/VHRM.S29284>
33. , Y., Yang, H., Chen, Y. et al. (2025) Construction and diagnostic efficacy assessment of the urinary exosomal miRNA-mRNA network in children with IgA vasculitis nephritis. FASEB J. 39, e70492.
<https://doi.org/10.1096/fj.202403111R>
34. , Q., Liu, J., Sun, Y. et al. (2022) Expression of miR-342-3p in rheumatoid arthritis patients and its effect on synovial fibroblast inflammation and migration. Nan Fang Yi Ke Da Xue Xue Bao, 42, 1712-1719. (in Chinese)
